Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
“Yesterday’s vote in the European Parliament marks an important shift in how Europe prepares for and protects access to critical medicines. The SANT Committee’s decision to refine the scope of the Critical Medicines Act (CMA), by recognising the distinct characteristics of different pharmaceutical supply chains, is a welcome move.
For the CMA to reach its full potential and properly safeguard patients, it needs to account for how medicines are actually developed and manufactured. Plasma-derived medicines, which rely on voluntary donations and complex production processes, demonstrate why tailored policy solutions and regulatory flexibility are essential.
As the trilogues will begin in the new year, I look forward to Council of the European Union and European Commission to align with the EP’s position on this matter.
I also urge policymakers to keep patients at the centre of their thinking during these negotiations. Access and availability of medicines must be prioritised. Unilateral and uncoordinated national stockpiling can have unwanted consequences on PDMP supply, which is why PPTA Europe recommends avoiding national stockpiling and limiting EU-level stockpiling to clearly defined crisis situations.

Read PPTA’s full statement in response to the recent vote.”
Read more about PPTA updates on Hemostasis Today.
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition